S-(2,4-dinitrophenyl)glutathione
Also known as: DNP-SG, Glutathione-DNP conjugate, GS-DNP, S-(2,4-dinitrophenyl)-glutathione
Summary
S-(2,4-dinitrophenyl)glutathione is a synthetic glutathione conjugate produced enzymatically from glutathione and 1-chloro-2,4-dinitrobenzene via glutathione S-transferase catalysis. It serves primarily as a biochemical research tool and probe for measuring GST activity in cell lysates and for studying MRP1/MRP2-mediated export mechanisms. It has no clinical application.
Mechanism of Action
S-(2,4-dinitrophenyl)glutathione (DNP-SG) is formed via conjugation of glutathione with 1-chloro-2,4-dinitrobenzene (CDNB) catalyzed by glutathione S-transferases (GSTs). It acts as a substrate and inhibitor of multidrug resistance-associated proteins (MRPs/ABCCs), particularly MRP1 and MRP2, which actively transport it out of cells. It is used as a probe to study GST activity, MRP-mediated transport, and cellular detoxification pathways.
Routes of Administration
No administration routes recorded yet.
Goals & Uses
- Multidrug resistance investigationResearch / OncologyModerate
- GST activity measurementResearch / Biochemical AssayHigh
- Cellular detoxification pathway studiesResearch / ToxicologyModerate
- MRP1/MRP2 transport characterizationResearch / Transporter BiologyHigh
Contraindications
- Human therapeutic useRegulatory/safetyHigh
Adverse Effects
- Cytotoxicity (in vitro)ToxicityCommon
Drug Interactions
- MRP1/ABCC1 inhibitors (e.g., MK-571)Low
Population Constraints
- All human populationsGeneralAbsolute
Regulatory Status
- European UnionUnapprovedNo EMA regulatory status; used solely as a laboratory biochemical.
- United StatesUnapprovedResearch reagent only; not reviewed or approved by the FDA for any therapeutic indication.
- United KingdomUnapprovedNo MHRA regulatory status; research use only.
No regulatory approval in any jurisdiction. Used exclusively as a biochemical research reagent. Not intended for human or veterinary therapeutic use.
Evidence & Sources
No sources recorded yet.